Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

著者: John Farley, William E. Brady, Vinod Vathipadiekal, Heather A. Lankes, Robert L. Coleman, Mark A. Morgan, Robert S. Mannel, S. Diane Yamada, David G. Mutch, William H. Rodgers, Michael J. Birrer, David M. Gershenson - The Lancet 2012 被引用: 413